PD-LI Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA

被引：0

作者：

Fernandez-Bussy, Sebastian ^{[1
]}

Pires, Yumay ^{[2
]}

Labarca, Gonzalo ^{[3
,4
]}

Vial, Macarena R. ^{[1
]}

机构：

[1] Univ Desarrollo, Clin Alemana Santiago, Unidad Neumol Intervencionista, Santiago, Chile

[2] Univ Desarrollo, Clin Alemana Santiago, Dept Anat Patol, Santiago, Chile

[3] Univ San Sebastian, Fac Med, Concepcion, Chile

[4] Complejo Asistencial Dr Victor Rios Ruiz, Dept Med Interna, Los Angeles, Chile

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2018年 / 54卷 / 05期

关键词：

CHEMOTHERAPY; DOCETAXEL; NIVOLUMAB;

D O I：

10.1016/j.arbr.2017.10.019

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：290 / 292

页数：3

共 50 条

[21] PD-L1 Testing of EBUS-TBNA Samples Acquired for the Diagnosis and Staging of Non-Small Cell Lung Cancer: Feasibility and Results
Smith, A.
Wang, H.
Zerbo, A.
Beaudoin, S.
Ofiara, L. M.
Benedetti, A.
Gonzalez, A. V.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[22] PILOT DATA ON THE ADEQUACY FOR NEXT GENERATION SEQUENCING IN EBUS-TBNA SPECIMEN VS LIQUID BIOPSIES IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
Ferguson, Travis L.
Thiboutot, Jeffrey
Pastis, Nicholas J.
Gilbert, Christopher R.
Fox, Adam
Tanner, Nichole T.
Yarmus, Lonny B.
Ward, Ralph
Pai, Cheryl
Josan, Enambir
Ghattas, Christian
Pannu, Jasleen K.
Revelo, Alberto E.
Silvestri, Gerard A.
CHEST, 2023, 164 (04) : 4179A - 4180A
[23] Negative EBUS-TBNA Predicts Very Low Prevalence of Mediastinal Disease in Staging of Non-Small Cell Lung Cancer
Taverner, John
Cheang, Mun-Yoong
Antippa, Phillip
See, Katharine
Irving, Louis B.
Steinfort, Daniel P.
JOURNAL OF BRONCHOLOGY & INTERVENTIONAL PULMONOLOGY, 2016, 23 (02) : 177 - 180
[24] Comparative Study Between Adenocarcinoma And Squamous Cell Carcinoma In Advanced Non-Small Cell Lung Cancer Diagnosed By Ebus-Tbna
Lee, Y. -M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[25] Expression of PD-L1 in neoplastic samples obtained by EBUS-TBNA
Errasti, Javier
Torralba, Laura
Javier Vengoechea, Jose
Sobrino, Almudena
Irene Bermudez, Rocio
Minchole, Elisa
Lucia Figueredo, Ana
Vera, Elisabet
Gambo, Paula
Alvarez, Ramiro
Bello, Salvador
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[26] Protocol to Improve Genotyping of Non-Small-Cell Lung Cancer Diagnosed Using EBUS-TBNA
Bellinger, Christina R.
Sharma, Deepankar
Dotson, Travis
Ruiz, Jimmy
Parks, Graham
Haponik, Edward F.
SOUTHERN MEDICAL JOURNAL, 2018, 111 (10) : 601 - 606
[27] Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Tan, Shera
Sharma, Kiran
Tham, Kah Yee
Ang, Shin Yuh
Van Hai Nguyen
Lapperre, Therese Sophie
Loo, Chian Min
Koh, Mariko Siyue
EUROPEAN RESPIRATORY JOURNAL, 2014, 44
[28] EBUS-TBNA LYMPH NODE NOMENCLATURE AND VARIATIONS ACROSS STAGING MODALITIES FOR NON-SMALL CELL LUNG CARCINOMA
Belousova, N.
Bewes, T.
Zhang, L.
Havryk, A.
Stone, E.
RESPIROLOGY, 2015, 20 : 149 - 149
[29] Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients: a pilot study
Guarize, Juliana
Rocco, Elena Guerini
de Marinis, Filippo
Sedda, Giulia
Bertolaccini, Luca
Donghi, Stefano Maria
Casiraghi, Monica
Di Tonno, Clementina
Barberis, Massimo
Spaggiari, Lorenzo
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (04)
[30] The inflamed phenotype in PD-Li negative non-small cell lung cancer (NSCLC) and response to checkpoint inhibitors
Pabla, Sarabjot
Dy, Grace
Nesline, Mary
Gandhi, Shipra
Pandey, Manu
Ernstoff, Marc C.
Conroy, Jeffrey M.
Glenn, Sean
Burgher, Blake
Andreas, Jonathan
Giamo, Vincent
Papanicolau-Sengos, Antonios
Galluzzi, Lorenzo
He, Ji
Gardner, Mark
Morrison, Carl
JOURNAL OF IMMUNOLOGY, 2017, 198 (01):

← 1 2 3 4 5 →